Cited by 247Amyotrophic Lateral Sclerosis ResearchRNA Research and SplicingHereditary Neurological Disorders

The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth

Open access
Fallini, Claudia, Bassell, Gary J., Rossoll, Wilfried·2012·Human Molecular Genetics

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease specifically affecting cortical and spinal motor neurons. Cytoplasmic inclusions containing hyperphosphorylated and ubiquitinated TDP-43 are a pathological hallmark of ALS, and mutations in the gene encoding TDP-43 have been directly linked to the development of the disease. TDP-43 is a ubiquitous DNA/RNA-binding protein with a nuclear role in pre-mRNA splicing. However, the selective vulnerability and axonal degeneration of motor neurons in ALS pose the question of whether TDP-43 may have an additional role in the regulation of the cytoplasmic and axonal fate of mRNAs, processes important for neuron function. To investigate this possibility, we have characterized TDP-43 localization and dynamics in primary cultured motor neurons. Using a combination of cell imaging and biochemical techniques, we demonstrate that TDP-43 is localized and actively transported in live motor neuron axons, and that it co-localizes with well-studied axonal mRNA-binding proteins. Expression of the TDP-43 C-terminal fragment led to the formation of hyperphosphorylated and ubiquitinated inclusions in motor neuron cell bodies and neurites, and these inclusions specifically sequestered the mRNA-binding protein HuD. Additionally, we showed that overexpression of full-length or mutant TDP-43 in motor neurons caused a severe impairment in axon outgrowth, which was dependent on the C-terminal protein-interacting domain of TDP-43. Taken together, our results suggest a role of TDP-43 in the regulation of axonal growth, and suggest that impairment in the post-transcriptional regulation of mRNAs in the cytoplasm of motor neurons may be a major factor in the development of ALS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/dds205

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ELAVL4 co-localizes with FUS in cytoplasmic speckles and stress granules.

    “co-localizes with FUS in cytoplasmic speckles and stress granules”

    From ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids (2021) · cites this paper as Fallini et al., 2012

    The Discussion states that HuD and a pathogenic FUS variant have both been shown to be components of stress granules. It does not establish that they co-localize with each other there or in cytoplasmic speckles; the paper’s co-localization findings concern HuD and TDP-43. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • ELAVL4 is present in TAR DNA-binding protein 43 (TDP-43) inclusions.

    “is present in TAR DNA-binding protein 43 (TDP-43) inclusions (Fallini et al., 2012; De Santis et al., 2019).”
  • ELAVL4 is a target of FUS activity.

    “ELAVL4 is a target of FUS activity”

    From ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids (2021) · cites this paper as Fallini et al., 2012

    The Discussion describes FUS as a regulator of neuronal mRNA transport and stability, and separately discusses HuD and other ELAV-family proteins in relation to TDP-43 aggregates. Searches for ELAVL4 as a FUS target and for FUS regulation of HuD found no passage connecting them in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Wilson, A.C., Dugger, B.N., Dickson, D.W. and Wang, D.S. (2011) TDP-43 in aging and Alzheimer's disease -a review. Int. J. Clin. Exp. Pathol., 4, 147-155.
  2. Colombrita, C., Zennaro, E., Fallini, C., Weber, M., Sommacal, A., Buratti, E., Silani, V. and Ratti, A. (2009) TDP-43 is recruited to 3716 Human Molecular Genetics, 2012, Vol. 21, No. 16 stress granules in conditions of oxidative insult. J. Neurochem., 111, 1051-1061.
  3. von Roretz, C., Di Marco, S., Mazroui, R. and Gallouzi, I.E. (2011) Turnover of AU-rich-containing mRNAs during stress: a matter of survival. Wiley Interdiscip. Rev. RNA, 2, 336-347.
  4. Fallini, C., Bassell, G.J. and Rossoll, W. (2012) Spinal muscular atrophy: the role of SMN in axonal mRNA regulation. Brain Res. http://dx.doi.org/ 10.1016/j.brainres.2012.01.044. · DOI
  5. Couthouis, J., Hart, M.P., Shorter, J., Dejesus-Hernandez, M., Erion, R., Oristano, R., Liu, A.X., Ramos, D., Jethava, N., Hosangadi, D. et al. (2011) Feature article: From the cover: a yeast functional screen predicts new candidate ALS disease genes. Proc. Natl Acad. Sci. USA, 108, 20881-20890.
  6. Miles, G.B., Yohn, D.C., Wichterle, H., Jessell, T.M., Rafuse, V.F. and Brownstone, R.M. (2004) Functional properties of motoneurons derived from mouse embryonic stem cells. J. Neurosci., 24, 7848 -7858. 3718 Human Molecular Genetics, 2012, Vol. 21, No. 16

Cited by

Sorted by citations

Authors
Fallini, C., Bassell, G. J., & Rossoll, W.
Affiliations
Emory University (US)
Corresponding author
  • Bassell, Gary J.
  • Rossoll, Wilfried
Venue
Human Molecular Genetics
Published
2012-05-28
Volume
21
Issue
16
Pages
3703-3718
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2146627025
Cited by
247
References
4
Citations by year
2026: 7 · 2025: 20 · 2024: 15 · 2023: 15 · 2022: 12 · 2021: 24 · 2020: 18 · 2019: 18 · 2018: 29 · 2017: 22 · 2016: 14 · 2015: 8 · 2014: 19 · 2013: 17 · 2012: 9
FWCI
11.08
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Muscular Dystrophy Association
  • Emory University (P30NS055077)
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (P30NS055077)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD055835, HD055835)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
TDP-43, amyotrophic lateral sclerosis, motor neurons, axonal transport, axon growth, HUD, mRNA-binding proteins, cytoplasmic inclusions, hyperphosphorylation, ubiquitination, post-transcriptional regulation, C-terminal domain
MeSH terms
ELAV-Like Protein 4, Amyotrophic Lateral Sclerosis, Animals, Axons, Cells, Cultured, Cytoplasm, DNA-Binding Proteins, Humans, Mice, Transgenic, Motor Neurons, Mutation, Phosphorylation, RNA, Messenger, Brain-Derived Neurotrophic Factor, Protein Transport, Mice, ELAV Proteins, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review